Massimo Terzolo

22.4k total citations · 6 hit papers
257 papers, 12.0k citations indexed

About

Massimo Terzolo is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cancer Research. According to data from OpenAlex, Massimo Terzolo has authored 257 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 187 papers in Endocrinology, Diabetes and Metabolism, 170 papers in Surgery and 100 papers in Cancer Research. Recurrent topics in Massimo Terzolo's work include Adrenal and Paraganglionic Tumors (168 papers), Pituitary Gland Disorders and Treatments (128 papers) and Cancer, Hypoxia, and Metabolism (99 papers). Massimo Terzolo is often cited by papers focused on Adrenal and Paraganglionic Tumors (168 papers), Pituitary Gland Disorders and Treatments (128 papers) and Cancer, Hypoxia, and Metabolism (99 papers). Massimo Terzolo collaborates with scholars based in Italy, Germany and United States. Massimo Terzolo's co-authors include Giuseppe Reimondo, Alberto Angeli, Martin Faßnacht, G. Osella, Silvia Bovio, Olaf M. Dekkers, P. Paccotti, Alfredo Berruti, Anna Pia and Fulvia Daffara and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Massimo Terzolo

251 papers receiving 11.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors

2016 996 citations Martin Faßnacht, Wiebke Arlt et al. European Journal of Endocrinology profile →
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors

2018 562 citations Martin Faßnacht, Olaf M. Dekkers et al. European Journal of Endocrinology profile →
Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

2006 505 citations Giuseppe Reimondo, Paola Sperone et al. profile →
AME Position Statement on adrenal incidentaloma

2011 361 citations Massimo Terzolo, Antonio Stigliano et al. European Journal of Endocrinology profile →
European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors

2023 261 citations Martin Faßnacht, Stylianos Tsagarakis et al. European Journal of Endocrinology profile →
Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up

2020 238 citations Martin Faßnacht, Harm R. Haak et al. profile →

Peers

Countries citing papers authored by Massimo Terzolo

Since Specialization

Citations

This map shows the geographic impact of Massimo Terzolo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Terzolo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Terzolo more than expected).

Fields of papers citing papers by Massimo Terzolo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Terzolo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Terzolo. The network helps show where Massimo Terzolo may publish in the future.

Co-authorship network of co-authors of Massimo Terzolo

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Terzolo. A scholar is included among the top collaborators of Massimo Terzolo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Terzolo. Massimo Terzolo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis 2023 ·European Journal of Endocrinology ·Iris C. M. Pelsma, Martin Faßnacht, Stylianos Tsagarakis, Massimo Terzolo, Antoine Tabarin, Anju Sahdev, John Newell‐Price, Ljiljana Marina, Kerstin Lorenz, Irina Bancos, Wiebke Arlt, Olaf M. Dekkers	47
2	Albumin/Mitotane Interaction Affects Drug Activity in Adrenocortical Carcinoma Cells: Smoke and Mirrors on Mitotane Effect with Possible Implications for Patients’ Management 2023 ·International Journal of Molecular Sciences ·(unknown), L. Saba, Gianluca Catucci, Jessica Petiti, Soraya Puglisi, (unknown), Giuseppe Reimondo, Gianfranco Gilardi, Claudia Giachino, Massimo Terzolo, Marco Lo Iacono	2
3	The management of postoperative disease recurrence in patients with adrenocortical carcinoma: a retrospective study in 106 patients 2023 ·European Journal of Endocrinology ·Anna Calabrese, Soraya Puglisi, (unknown), Vittoria Basile, Paola Perotti, Anna Pia, Paola Berchialla, Marco Volante, Cristian Fiori, F. Porpiglia, Andrea Veltri, Giuseppe Reimondo, Massimo Terzolo	7
4	Long-Term Consequences of Cushing Syndrome: A Systematic Literature Review 2023 ·The Journal of Clinical Endocrinology & Metabolism ·Soraya Puglisi, (unknown), (unknown), Francesco Oliva, Massimo Terzolo	17
5	European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors breakdown → 2023 ·European Journal of Endocrinology ·Martin Faßnacht, Stylianos Tsagarakis, Massimo Terzolo, Antoine Tabarin, Anju Sahdev, John Newell‐Price, Iris C. M. Pelsma, Ljiljana Marina, Kerstin Lorenz, Irina Bancos, Wiebke Arlt, Olaf M. Dekkers	261
6	Relacorilant, a Selective Glucocorticoid Receptor Modulator, Induces Clinical Improvements in Patients With Cushing Syndrome: Results From A Prospective, Open-Label Phase 2 Study 2021 ·Frontiers in Endocrinology ·Rosario Pivonello, Irina Bancos, Richard A. Feelders, Atil Y. Kargi, Janice M. Kerr, Murray B. Gordon, Cary N. Mariash, Massimo Terzolo, Noel Ellison, Andreas Moraitis	44
7	Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System 2021 ·Frontiers in Endocrinology ·Soraya Puglisi, Alessandro Rossini, Roberta Poli, (unknown), Anna Pia, Massimo Terzolo, Giuseppe Reimondo	93
8	Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation 2020 ·European Radiology ·Andrea Veltri, (unknown), Marco Calandri, (unknown), Marco Volante, F. Porpiglia, Anna Calabrese, Soraya Puglisi, Vittoria Basile, Massimo Terzolo	15
9	Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study 2020 ·The Journal of Clinical Endocrinology & Metabolism ·Isabel Weigand, Barbara Altieri, (unknown), Vittoria Basile, Stefan Kircher, Laura‐Sophie Landwehr, Jochen Schreiner, Maria Cláudia Nogueira Zerbini, Cristina L. Ronchi, Felix Megerle, Alfredo Berruti, Letizia Canu, Marco Volante, Isabel Paiva, Silvia Della Casa, Silviu Sbiera, Martin Faßnacht, Maria Candida Barisson Villares Fragoso, Massimo Terzolo, Matthias Kroiß	21
10	Effects on bone health of glucocorticoid replacement therapy in primary and secondary adrenal insufficiency: A review 2018 ·Current Opinion in Endocrine and Metabolic Research ·(unknown), G. Osella, A. Pia, Massimo Terzolo	3
11	Autonomous hypercortisolism: definition and clinical implications 2018 ·PubMed ·Giuseppe Reimondo, Soraya Puglisi, Anna Pia, Massimo Terzolo	13
12	Ribonucleotide Reductase Large Subunit ( RRM1 ) Gene Expression May Predict Efficacy of Adjuvant Mitotane in Adrenocortical Cancer 2012 ·Clinical Cancer Research ·Marco Volante, Massimo Terzolo, Martin Faßnacht, Ida Rapa, Antonina Germano, Silviu Sbiera, Fulvia Daffara, Paola Sperone, Giorgio V. Scagliotti, Bruno Allolio, Mauro Papotti, Alfredo Berruti	52
13	18-Hydroxycorticosterone, 18-hydroxycortisol and 18-oxocortisol in the diagnosis of primary aldosteronism and its subtypes. 2012 ·15th International & 14th European Congress of Endocrinology ·Paolo Mulatero, (unknown), Silvia Monticone, Jacopo Burrello, (unknown), Massimo Terzolo, (unknown), Elise P. Gómez-Sánchez, Clara Gomez-Sanchez, Franco Veglio	2
14	Cortisol secretion, bone health, and bone loss: a cross-sectional and prospective study in normal nonosteoporotic women in the early postmenopausal period 2012 ·European Journal of Endocrinology ·G. Osella, M. Ventura, Arianna Ardito, Barbara Allasino, A Termine, L. Saba, Rosetta Vitetta, Massimo Terzolo, A Angeli	23
15	AME Position Statement on adrenal incidentaloma breakdown → 2011 ·European Journal of Endocrinology ·Massimo Terzolo, Antonio Stigliano, Iacopo Chiodini, Paola Loli, Lino Furlani, Giorgio Arnaldi, Giuseppe Reimondo, A. Pia, Vincenzo Toscano, Michele Zini, Giorgio Borretta, Enrico Papini, Piernicola Garofalo, Bruno Allolio, B. Dupas, Franco Mantero, Antoine Tabarin	361
16	Etoposide, doxorubicin, cisplatin, and mitotane versus streptozotocin and mitotane in adrenocortical carcinoma: preliminary results from the first international phase III trial: the FIRM-ACT study 2011 ·Martin Faßnacht, Massimo Terzolo, Bruno Allolio, Éric Baudin, Harm R. Haak, Alfredo Berruti, Hans‐Helge Mueller, Britt Skogseid	2
17	Subclinical Cushing’s syndrome: definition and management 2011 ·Clinical Endocrinology ·Massimo Terzolo, A. Pia, Giuseppe Reimondo	80
18	Therapeutic concentrations of mitotane inhibit thyrotroph cell viability and TSH secretion in a mouse cell line model 2010 ·Institutional Research Information System University of Ferrara (University of Ferrara) ·Erica Gentilin, Fulvia Daffara, Giuseppe Reimondo, (unknown), Maria Rosaria Ambrosio, Massimo Terzolo, (unknown), Maria Chiara Zatelli	3
19	A new simple HPLC method for measuring mitotane and its two principal metabolites 2006 ·Journal of Chromatography B ·(unknown), Elisa Pirro, (unknown), Francesca Martino, Andrea Elio Sprio, Fulvia Daffara, Massimo Terzolo, Alfredo Berruti, Francesco Di Carlo, (unknown)	27
20	Melatonin relationship to human tumors 1987 ·Luigi Dogliotti, M. Torta, Alfredo Berruti, (unknown), Massimo Terzolo, R. Faggiuolo	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact